Discovery of a New Class of Protein Farnesyltransferase Inhibitors in the Arylthiophene Series

被引:29
|
作者
Lethu, Sebastien [1 ]
Ginisty, Maryon [1 ]
Bosc, Damien [1 ]
Dubois, Joelle [1 ]
机构
[1] CNRS, Ctr Rech Gif sur Yvette, Inst Chim Subst Nat, UPR2301, F-91198 Gif Sur Yvette, France
关键词
THIOPHENES;
D O I
10.1021/jm901280q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Screening of the ICSN chemical library led to the discovery of 3-(4-chlorophenyl)-4-cyano-5-thioalkylthiophene 2-carboxylic acids as potent farnesyltransferase inhibitors. Enzymatic kinetic studies showed that this original FTI series belongs to the CaaX competitive inhibitor class. Preliminary SAR studies allowed its to improve the IC50 from 110 to 7.5 nM.
引用
收藏
页码:6205 / 6208
页数:4
相关论文
共 50 条
  • [41] Protein farnesyltransferase inhibitors exhibit potent antimalarial activity
    Nallan, L
    Bauer, KD
    Bendale, P
    Rivas, K
    Yokoyama, K
    Hornéy, CP
    Pendyala, PR
    Floyd, D
    Lombardo, LJ
    Williams, DK
    Hamilton, A
    Sebti, S
    Windsor, WT
    Weber, PC
    Buckner, FS
    Chakrabarti, D
    Gelb, MH
    Van Voorhis, WC
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (11) : 3704 - 3713
  • [42] Discovery of a new class of p38 kinase inhibitors
    Dumas, J
    Sibley, R
    Riedl, B
    Monahan, MK
    Lee, W
    Lowinger, TB
    Redman, AM
    Johnson, JS
    Kingery-Wood, J
    Scott, WJ
    Smith, RA
    Bobko, M
    Schoenleber, R
    Ranges, GE
    Housley, TJ
    Bhargava, A
    Wilhelm, SM
    Shrikhande, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2047 - 2050
  • [43] Discovery of thienopyrimidinones as a new series of potent phosphodiesterase 7 inhibitors
    Endo, Yusuke
    Kawai, Kentaro
    Asano, Takeshi
    Amano, Seiji
    Sawada, Keisuke
    Ogura, Keiji
    Ueo, Noriko
    Takahashi, Nobuaki
    Sonoda, Yo
    Nagai, Mika
    Kamei, Noriyuki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [44] A new class of prolylcarboxypeptidase inhibitors, Part 1: Discovery and evaluation
    Graham, Thomas H.
    Liu, Wensheng
    Verras, Andreas
    Sebhat, Iyassu K.
    Xiong, Yusheng
    Bleasby, Kelly
    Bhatt, Urmi R.
    Chen, Qing
    Garcia-Calvo, Margarita
    Geissler, Wayne M.
    Gorski, Judith N.
    He, Huaibing
    Lassman, Michael E.
    Lisnock, JeanMarie
    Li, Xiaohua
    Shen, Zhu
    Tong, Xinchun
    Tung, Elaine C.
    Wiltsie, Judyann
    Xiao, Jianying
    Xie, Dan
    Xu, Suoyu
    Hale, Jeffrey J.
    Pinto, Shirly
    Shen, Dong-Ming
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2811 - 2817
  • [45] STRUCTURE BASED DISCOVERY OF A NEW CLASS OF ENZYME INHIBITORS.
    Stout, Thomas J.
    Costi, M. Paola
    Barlocco, Daniela
    Rinaldi, Marcella
    Shoichet, Brian
    Perry, K. M.
    Kuntz, I. D.
    Stroud, Robert M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C207 - C207
  • [46] Discovery and parallel synthesis of a new class of cathepsin K inhibitors
    Smith, RA
    Bhargava, A
    Browe, C
    Chen, JS
    Dumas, J
    Hatoum-Mokdad, H
    Romero, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (22) : 2951 - 2954
  • [47] Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors
    Chen, Dongyin
    Huang, Xin
    Zhou, Hongwen
    Luo, Hanqiong
    Wang, Pengfei
    Chang, Yongzhi
    He, Xinyi
    Ni, Suiying
    Shen, Qingqing
    Cao, Guoshen
    Sun, Hongbin
    Wen, Xiaoan
    Liu, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 201 - 213
  • [48] BISUBSTRATE INHIBITORS OF FARNESYLTRANSFERASE - A NOVEL CLASS OF SPECIFIC INHIBITORS OF RAS TRANSFORMED-CELLS
    MANNE, V
    YAN, N
    CARBONI, JM
    TUOMARI, AV
    RICCA, CS
    BROWN, JG
    ANDAHAZY, ML
    SCHMIDT, RJ
    PATEL, D
    ZAHLER, R
    WEINMANN, R
    DER, CJ
    COX, AD
    HUNT, JT
    GORDON, EM
    BARBACID, M
    SEIZINGER, BR
    ONCOGENE, 1995, 10 (09) : 1763 - 1779
  • [49] Recent developments in the discovery of protein kinase inhibitors from the urea class
    Dumas, J
    Smith, RA
    Lowinger, TB
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (05) : 600 - 616
  • [50] Ras farnesyltransferase inhibitors as a new class of antitumor agents: A chemical approach to controlling cell signaling.
    Qian, YM
    Vogt, A
    Sebti, SM
    Hamilton, AD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 12 - COMP